84 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B Buy
Article Searches
Amgen Set For 2019 With Aimovig, Repatha, And Rest Of Pipeline https://seekingalpha.com/article/4229478-amgen-set-2019-aimovig-repatha-rest-pipeline?source=feed_sector_healthcare Dec 20, 2018 - Aimovig should drive Amgen revenue higher in Q4.2019 should be a solid year.Watch for 2019 guidance in January.
AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib http://www.zacks.com/stock/news/344208/abbvie-abbv-seeks-approval-for-ra-candidate-upadacitinib?cid=CS-ZC-FT-344208 Dec 21, 2018 - AbbVie (ABBV) submits regulatory applications in the United States and EU for upadacitinib, for the treatment of adult patients with moderate to severe rheumatoid arthritis.
Barron's 10 Picks For 2019 Vs. Kiplinger's 12 Forever Stocks Show Target Gains And Losses https://seekingalpha.com/article/4229937-barrons-10-picks-2019-vs-kiplingers-12-forever-stocks-show-target-gains-losses?source=feed_all_articles Dec 24, 2018 - The December 17 issue of Barron's featured 10 favorite picks for the year ahead, while Kiplinger Today on December 21 proclaimed 12 Stocks You Should Never Sell.The top analyst-target-augured NET-GAIN
Four Dividend Growth Stocks To Think About For The New Year https://seekingalpha.com/article/4230207-four-dividend-growth-stocks-think-new-year?source=feed_all_articles Dec 26, 2018 - Broad market declines have increased the yields of some dividend growth stocks to values seen in the last recession.High quality companies with growing dividends are only periodically undervalued and
Share In Healthcare And Biotech Gains With 12% Yield From This Tekla Fund https://seekingalpha.com/article/4230208-share-healthcare-biotech-gains-12-percent-yield-tekla-fund?source=feed_sector_healthcare Dec 27, 2018 - The biotech sector not only has helped to discover cures to difficult medical problems but also has outperformed the broader market. Tekla Healthcare Investors (HQH) is a CEF which provides investors
Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis http://www.zacks.com/stock/news/345011/spectrum-pharma-files-bla-for-neutropenia-candidate-rolontis?cid=CS-ZC-FT-345011 Dec 28, 2018 - Spectrum Pharma (SPPI) petitions for a BLA to the FDA regarding its lead pipeline candidate, Rolontis, to address chemotherapy-induced neutropenia in patients with breast cancer.
'Safer Dividend Picks From Barron's 10 For 2019 And Kiplinger's 12 Forever Stocks https://seekingalpha.com/article/4230525-safer-dividend-picks-barrons-10-2019-kiplingers-12-forever-stocks?source=feed Dec 28, 2018 - The December 17 issue of Barron's featured 10 favorite picks for the year ahead. While Kiplinger Today December 21 proclaimed 12 Stocks You Should Never Sell. This shows 'safer' picks.Of the 22 equiti
Is Arrowhead The Biotech Play You've Been Waiting For? https://seekingalpha.com/article/4230817-arrowhead-biotech-play-waiting?source=feed_sector_healthcare Dec 31, 2018 - Arrowhead’s recent agreement with Janssen Pharmaceuticals further validates both new TRiM Platform and ARO-HBV program.The deal allows funding for the next 6 to 8 years of Arrowhead’s operations.Pre-c
What The Celgene Deal Means For The Biotech Sector https://seekingalpha.com/article/4231701-celgene-deal-means-biotech-sector?source=feed_sector_healthcare Jan 07, 2019 - On Jan. 3, pharma giant Bristol-Myers Squibb announced its intention to acquire Celgene, one of the largest biotech companies in the world, for $74 billion; the deal awaits shareholder approval.The bu
5 Blue Chips That Offer Great Buy-Write Opportunities https://seekingalpha.com/article/4231895-5-blue-chips-offer-great-buy-write-opportunities?source=feed_all_articles Jan 07, 2019 - If done consistently and properly, options are wonderful tools to generate reliable monthly income. No matter what type of investor you are, the following option strategies can be used for various pur

Pages: 123456...9

Page 1>

Related Companies

Name Exchange Price Mkt Cap
GILD Gilead Sciences, Inc. NASDAQ $72.78 $94.35B
BIIB Biogen Inc. NASDAQ $334.44 $67.37B
SGEN Seattle Genetics, Inc. NASDAQ $76.15 $12.09B
NBIX Neurocrine Biosciences, Inc. NASDAQ $117.38 $10.62B
QGEN Qiagen N.V. NASDAQ $37.42 $8.5B
Sector: Health Care > Industry: Biotechnology: Biological Products (No Diagnostic Substances)
DeepLinks for Amgen
AMGN - Google Finance https://www.google.com/finance?q=AMGN Industry related info and international coverage Summary News
AMGN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=AMGN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options